Atropine
Arrhythmia
Medical University of ViennaSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Arrhythmia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
WARFARIN Massachusetts General Hospital | Phase 3 | BB |
Flecainide Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
HUMAN RELAXIN 1 Deeptankar DeMazumder | Phase 1/2 | CCC |
PROPOFOL 4th Military Clinical Hospital with Polyclinic, Poland | N/A | D |
Rocuronium 4th Military Clinical Hospital with Polyclinic, Poland | N/A | D |
Same molecule, other indications
Atropine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →